|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4761470A
(en)
|
1985-12-16 |
1988-08-02 |
Merck & Co., Inc. |
Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody
|
|
US5605884A
(en)
|
1987-10-29 |
1997-02-25 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Factor VIII formulations in high ionic strength media
|
|
US4877608A
(en)
|
1987-11-09 |
1989-10-31 |
Rorer Pharmaceutical Corporation |
Pharmaceutical plasma protein formulations in low ionic strength media
|
|
US5137819A
(en)
|
1988-07-08 |
1992-08-11 |
University Of British Columbia |
Cellulose binding fusion proteins for immobilization and purification of polypeptides
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
GB8915019D0
(en)
|
1989-06-30 |
1989-08-23 |
Matthews Ruth C |
Medicaments
|
|
DE4001451A1
(de)
|
1990-01-19 |
1991-08-01 |
Octapharma Ag |
Stabile injizierbare loesungen von faktor viii und faktor ix
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
SE9001705D0
(sv)
*
|
1990-05-11 |
1990-05-11 |
Medscand Ab |
Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
|
|
US6037135A
(en)
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
CA2118015A1
(en)
|
1992-04-14 |
1993-10-28 |
Jeffrey R. Marks |
Method of detecting tumors containing complexes of p53 and hsp70
|
|
CA2124690C
(en)
|
1992-10-02 |
2007-09-11 |
Thomas Osterberg |
Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
GB9501040D0
(en)
|
1995-01-19 |
1995-03-08 |
Quadrant Holdings Cambridge |
Dried composition
|
|
IL123218A0
(en)
|
1995-08-18 |
1998-09-24 |
Sloan Kettering Inst Cancer |
Heat shock protein-based vaccines and immunotherapies
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
JPH11513369A
(ja)
|
1995-09-13 |
1999-11-16 |
フォーダム ユニバーシティー |
熱ショックタンパク質を用いる治療及び予防方法
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
RS50101B
(sr)
|
1996-02-24 |
2009-01-22 |
Boehringer Ingelheim International Gmbh., |
Farmaceutski preparati za imunomodulaciju
|
|
US5763401A
(en)
|
1996-07-12 |
1998-06-09 |
Bayer Corporation |
Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
|
|
WO1998014207A1
(en)
|
1996-10-01 |
1998-04-09 |
Dana-Farber Cancer Institute |
Immunological therapy for cancer
|
|
US6231859B1
(en)
|
1996-12-02 |
2001-05-15 |
Aquila Biopharmaceuticals, Inc. |
Saponin adjuvant compositions
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
ES2265165T3
(es)
|
1997-07-10 |
2007-02-01 |
Mannkind Corporation |
Dispositivo para inducir una respuesta ltc.
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
EP0893507A1
(en)
|
1997-07-25 |
1999-01-27 |
Institut Gustave Roussy |
Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
|
|
DE19737409A1
(de)
*
|
1997-08-27 |
1999-03-04 |
Medigene Ag |
Diagnosekit für Hauttest und Verfahren zur Durchführung desselben
|
|
CA2302522C
(en)
|
1997-08-29 |
2010-08-17 |
Antigenics Llc |
Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
|
|
EP1030819A4
(en)
|
1997-09-30 |
2001-11-21 |
Cel Sci Corp |
CONJUGATED IMMUNOGENIC POLYPEPTIDE FOR THE TREATMENT OF HERPES SIMPLEX VIRUS
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
IL135860A0
(en)
|
1997-10-31 |
2001-05-20 |
Sloan Kettering Inst Cancer |
Conjugate heat shock protein-binding peptides
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
JP2002506633A
(ja)
|
1998-03-20 |
2002-03-05 |
ジェンザイム・コーポレーション |
Ｔ細胞応答を誘発するための遺伝子に基づくワクチンの組成物および使用法
|
|
NO315238B1
(no)
|
1998-05-08 |
2003-08-04 |
Gemvax As |
Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
|
|
SI1077722T1
(sl)
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
|
PT1104306E
(pt)
|
1998-08-10 |
2006-05-31 |
Antigenics Inc |
Composicoes de cpg e adjuvantes de saponina e seus metodos
|
|
SK4272001A3
(en)
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US7851591B1
(en)
|
1998-10-29 |
2010-12-14 |
Dana Farber Cancer Institute, Inc. |
Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT
|
|
PL354286A1
(en)
|
1999-08-23 |
2003-12-29 |
Dana-Farber Cancer Institutedana-Farber Cancer Institute |
Pd-1, a receptor for b7-4, and uses therefor
|
|
DK1234031T3
(en)
|
1999-11-30 |
2017-07-03 |
Mayo Foundation |
B7-H1, AN UNKNOWN IMMUNE REGULATORY MOLECULE
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
GB0004547D0
(en)
|
2000-02-23 |
2000-04-19 |
Immunobiology Ltd |
Screening method for novel vaccine candidates and compositions obtained thereby
|
|
US20020044948A1
(en)
|
2000-03-15 |
2002-04-18 |
Samir Khleif |
Methods and compositions for co-stimulation of immunological responses to peptide antigens
|
|
CA2406472A1
(en)
|
2000-04-17 |
2001-10-25 |
James E. Rothman |
Javelinization of protein antigens to heat shock proteins
|
|
EP1286693A4
(en)
|
2000-06-02 |
2005-07-13 |
Univ Connecticut Health Ct |
COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
US6989146B2
(en)
*
|
2000-08-09 |
2006-01-24 |
The Regents Of The University Of California |
Stress proteins and peptides and methods of use thereof
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
CN1635896A
(zh)
|
2001-08-20 |
2005-07-06 |
康涅狄格大学健康中心 |
包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
|
|
CA2466279A1
(en)
|
2001-11-13 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
|
US20040071656A1
(en)
|
2001-12-26 |
2004-04-15 |
Felix Wieland |
Modulation of heat-shock-protein-based immunotherapies
|
|
KR20040105736A
(ko)
|
2002-02-28 |
2004-12-16 |
안티제닉스 아이엔씨 |
스트레스 단백질의 올리고머화에 기초한 방법 및 산물
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003090686A2
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
JP2005533015A
(ja)
|
2002-05-02 |
2005-11-04 |
ユニバーシティー オブ コネティカット ヘルス センター |
抗体療法の有効性を増強するための熱ショックタンパク質の使用
|
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
|
US20050221350A1
(en)
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
AU2003281200A1
(en)
|
2002-07-03 |
2004-01-23 |
Tasuku Honjo |
Immunopotentiating compositions
|
|
WO2004007527A2
(en)
*
|
2002-07-11 |
2004-01-22 |
Incyte Corporation |
Secreted proteins
|
|
EP1576124A2
(en)
|
2002-10-07 |
2005-09-21 |
Antigenics Inc. |
Heat shock protein binding fragments of cd91, and uses thereof
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004074454A2
(en)
|
2003-02-20 |
2004-09-02 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
CA2514500A1
(en)
|
2003-02-20 |
2004-09-10 |
University Of Connecticut Health Center |
Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
|
|
CN1780850A
(zh)
*
|
2003-02-28 |
2006-05-31 |
抗基因公司 |
凝集素在促进糖蛋白和抗原分子的低聚反应中的用途
|
|
EP1617804A4
(en)
|
2003-04-11 |
2007-07-25 |
Antigenics Inc |
IMPROVED VACCINE BASED ON HEAT SHOCK PROTEINS AND IMMUNOTHERAPIES
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
CA2538794C
(en)
|
2003-09-12 |
2016-04-19 |
Antigenics, Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
AU2003290460A1
(en)
*
|
2003-12-24 |
2005-07-14 |
Leiden University Medical Center |
Synthetic protein as tumor-specific vaccine
|
|
WO2005076009A2
(en)
|
2004-01-28 |
2005-08-18 |
Immatics Biotechnologies Gmbh |
Method for identifying and quantifying of tumour-associated peptides
|
|
US20090304679A1
(en)
|
2004-05-27 |
2009-12-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
US8252893B2
(en)
*
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
WO2006105255A2
(en)
|
2005-03-29 |
2006-10-05 |
The Board Of Trustees Of The University Of Illinois |
Cancer vaccines and therapeutic methods
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
WO2006120038A2
(en)
|
2005-05-09 |
2006-11-16 |
Vaxon Biotech |
Use of native peptides and their optimized derivatives for vaccination
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
US9732131B2
(en)
|
2006-02-27 |
2017-08-15 |
Calviri, Inc. |
Identification and use of novopeptides for the treatment of cancer
|
|
JP2009532664A
(ja)
|
2006-02-27 |
2009-09-10 |
アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティ |
癌の治療のためのノボペプチドの同定および使用
|
|
WO2008027800A2
(en)
|
2006-08-29 |
2008-03-06 |
Temple University - Of The Commonwealth System Of Higher Education |
Method for enhancing the efficacy of antigen specific tumor immunotherapy
|
|
AT504160A1
(de)
|
2006-09-11 |
2008-03-15 |
Ralf Dr Kircheis |
Verwendung einer mehrkomponenten-tumorvakzine
|
|
WO2008035350A1
(en)
|
2006-09-21 |
2008-03-27 |
Vaxil Biotherapeutics Ltd. |
Antigen specific multi epitope vaccines
|
|
US7998486B2
(en)
|
2006-10-25 |
2011-08-16 |
Newlink Genetics Corporation |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
|
|
DE102006060824B4
(de)
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
|
|
CN103736086A
(zh)
|
2007-02-15 |
2014-04-23 |
曼康公司 |
用于增强t细胞应答的方法
|
|
US8140270B2
(en)
|
2007-03-22 |
2012-03-20 |
National Center For Genome Resources |
Methods and systems for medical sequencing analysis
|
|
MX2009012922A
(es)
*
|
2007-05-31 |
2010-07-05 |
Academisch Ziekenhuis Leiden H |
Vacunacion intradermica de un peptido del virus del papiloma humano.
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
US8926961B2
(en)
*
|
2007-10-03 |
2015-01-06 |
Board Of Trustees Of The University Of Arkansas |
HPV E6 protein T cell epitopes and uses thereof
|
|
CN101970499B
(zh)
|
2008-02-11 |
2014-12-31 |
治疗科技公司 |
用于肿瘤治疗的单克隆抗体
|
|
EP2626081B1
(en)
|
2008-02-14 |
2017-03-22 |
Life Sciences Research Partners VZW |
Immunogenic control of tumours and tumour cells
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
EP2113253B1
(en)
|
2008-04-30 |
2010-03-31 |
Immatics Biotechnologies GmbH |
Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
|
|
JP2009273377A
(ja)
|
2008-05-12 |
2009-11-26 |
Igaku Seibutsugaku Kenkyusho:Kk |
Ｍｈｃクラスｉ分子と結合し癌細胞の表面に表出されるペプチド候補の選択方法
|
|
JP5465720B2
(ja)
|
2008-07-08 |
2014-04-09 |
インサイト・コーポレイション |
インドールアミン２，３−ジオキシゲナーゼの阻害剤としての１，２，５−オキサジアゾール
|
|
AU2009288730B2
(en)
|
2008-08-25 |
2013-06-20 |
Amplimmune, Inc. |
Compositions of PD-1 antagonists and methods of use
|
|
EP2344191A4
(en)
*
|
2008-09-02 |
2013-02-13 |
Antigen Express Inc |
HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE
|
|
AU2009290544B2
(en)
|
2008-09-12 |
2015-07-16 |
Oxford University Innovation Limited |
PD-1 specific antibodies and uses thereof
|
|
US8552154B2
(en)
|
2008-09-26 |
2013-10-08 |
Emory University |
Anti-PD-L1 antibodies and uses therefor
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
RU2011144575A
(ru)
|
2009-04-03 |
2013-05-10 |
Эйдженус Инк. |
Способы получения и применения мультишаперон-антигенных комплексов
|
|
ES2533228T3
(es)
|
2009-06-09 |
2015-04-08 |
Vaxon Biotech |
Identificación, optimización y uso de epítopos compartidos de HLA-B*0702 para inmunoterapia
|
|
EP2476440B1
(en)
*
|
2009-09-11 |
2017-08-02 |
Proyecto de Biomedicina Cima, S.L. |
Therapeutic compositions for the treatment of hpv-induced diseases
|
|
PL2504364T3
(pl)
|
2009-11-24 |
2017-12-29 |
Medimmune Limited |
Ukierunkowane środki wiążące przeciwko B7-H1
|
|
US20130202623A1
(en)
|
2010-02-16 |
2013-08-08 |
Nicolas Chomont |
Pd-1 modulation and uses thereof for modulating hiv replication
|
|
EP2545078A1
(en)
|
2010-03-11 |
2013-01-16 |
UCB Pharma, S.A. |
Pd-1 antibody
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
EP2569633B1
(en)
|
2010-05-14 |
2016-02-10 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
AU2011255463A1
(en)
|
2010-05-21 |
2012-11-01 |
University Of Miami |
Cancer treatment
|
|
EP2576614A4
(en)
|
2010-05-24 |
2013-11-13 |
Phosimmune Inc |
CLASS I-MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
|
|
KR102042253B1
(ko)
|
2010-05-25 |
2019-11-07 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Ｂａｍｂａｍ：고처리율 서열분석 데이터의 병렬 비교 분석
|
|
US9646134B2
(en)
|
2010-05-25 |
2017-05-09 |
The Regents Of The University Of California |
Bambam: parallel comparative analysis of high-throughput sequencing data
|
|
FR2960542B1
(fr)
*
|
2010-05-27 |
2012-08-17 |
Esther Suzy Arlette Fellous |
Peptide en tant que medicament, en particulier pour le traitement du cancer
|
|
US10434197B2
(en)
|
2010-07-23 |
2019-10-08 |
University Of Delaware |
Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
|
|
KR102759126B1
(ko)
|
2010-12-30 |
2025-01-24 |
파운데이션 메디신 인코포레이티드 |
종양 샘플의 다유전자 분석의 최적화
|
|
BR112013023978B1
(pt)
|
2011-03-21 |
2021-09-08 |
Atlantic Cancer Research Institute |
Polipeptídeo com afinidade por proteínas de choque térmico e seu uso em diagnóstico de doença infecciosa, produção de resposta imune e tratamento de câncer, bem como ácido nucleico, composição e método de fracionamento de substância para pesquisa ou análise clínica de amostra biológica
|
|
WO2012129520A1
(en)
|
2011-03-24 |
2012-09-27 |
Texas Tech University System |
Tcr mimic antibodies as vascular targeting tools
|
|
MX2013011363A
(es)
|
2011-04-01 |
2014-04-25 |
Sloan Kettering Inst Cancer |
Anticuerpos para peptidos citosolicos.
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
WO2012159643A1
(en)
|
2011-05-24 |
2012-11-29 |
Biontech Ag |
Individualized vaccines for cancer
|
|
PL3892295T3
(pl)
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
CA2840018C
(en)
|
2011-07-24 |
2019-07-16 |
Curetech Ltd. |
Variants of humanized immunomodulatory monoclonal antibodies
|
|
AU2012302778B2
(en)
|
2011-08-31 |
2016-11-24 |
Mie University |
Vaccine preparation for cancer treatment
|
|
US8920075B2
(en)
|
2011-09-01 |
2014-12-30 |
Halo Maritime Defense Systems, Inc. |
Marine barrier and gate
|
|
KR101764096B1
(ko)
|
2011-11-28 |
2017-08-02 |
메르크 파텐트 게엠베하 |
항-ｐｄ-ｌ1 항체 및 그의 용도
|
|
WO2013158611A1
(en)
|
2012-04-16 |
2013-10-24 |
Agenus Inc. |
Methods and compositions for the treatment of glioblastomas
|
|
CA2886218A1
(en)
|
2012-05-25 |
2013-11-28 |
Phosimmune, Inc. |
Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
|
|
MX2014014199A
(es)
|
2012-05-25 |
2015-02-12 |
Bayer Healthcare Llc |
Sistema y procedimiento de prediccion de la inmunogenicidad de un peptido.
|
|
KR20220084444A
(ko)
|
2012-05-31 |
2022-06-21 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Pd-l1에 결합하는 항원 결합 단백질
|
|
WO2014012051A1
(en)
|
2012-07-12 |
2014-01-16 |
Persimmune, Inc. |
Personalized cancer vaccines and adoptive immune cell therapies
|
|
CN111499755A
(zh)
|
2012-08-03 |
2020-08-07 |
丹娜法伯癌症研究院 |
抗-pd-l1和pd-l2双结合抗体单一试剂及其使用方法
|
|
GB201214007D0
(en)
|
2012-08-07 |
2012-09-19 |
Scancell Ltd |
Anti-tumour immune responses to modified self-epitopes
|
|
EP2891099A4
(en)
|
2012-08-28 |
2016-04-20 |
Broad Inst Inc |
DETECTION OF DATA SEQUENCING AND BENCHMARKING VARIANTS
|
|
US9561266B2
(en)
|
2012-08-31 |
2017-02-07 |
University Of Virginia Patent Foundation |
Target peptides for immunotherapy and diagnostics
|
|
WO2014039675A2
(en)
|
2012-09-05 |
2014-03-13 |
University Of Virginia Patent Foundation |
Target peptides for colorectal cancer therapy and diagnostics
|
|
LT2901341T
(lt)
|
2012-09-28 |
2019-09-25 |
The University Of Connecticut |
Protekcinių vėžio epitopų identifikavimas, skirtas vėžio gydymui
|
|
BR112015007672A2
(pt)
|
2012-10-04 |
2017-08-08 |
Dana Farber Cancer Inst Inc |
anticorpos anti-pd-l1 monoclonais humanos e métodos de uso
|
|
EP3417874B1
(en)
|
2012-11-28 |
2024-09-11 |
BioNTech SE |
Individualized vaccines for cancer
|
|
WO2014088432A1
(en)
*
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
HK1216153A1
(zh)
|
2012-12-13 |
2016-10-21 |
University Of Virginia Patent Foundation |
用於卵巢癌治疗和诊断的靶向肽
|
|
AR093984A1
(es)
|
2012-12-21 |
2015-07-01 |
Merck Sharp & Dohme |
Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano
|
|
WO2014160902A1
(en)
|
2013-03-27 |
2014-10-02 |
Fred Hutchinson Cancer Research Center |
Directed immune stimulation
|
|
EP2983702A2
(en)
|
2013-04-07 |
2016-02-17 |
The Broad Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
|
SMT202100065T1
(it)
|
2013-05-02 |
2021-03-15 |
Anaptysbio Inc |
Anticorpi diretti contro la proteina della morte programmata (pd-1)
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
WO2014194302A2
(en)
|
2013-05-31 |
2014-12-04 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind pd-1
|
|
WO2014200910A2
(en)
|
2013-06-10 |
2014-12-18 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
US20160145355A1
(en)
|
2013-06-24 |
2016-05-26 |
Biomed Valley Discoveries, Inc. |
Bispecific antibodies
|
|
CN104250302B
(zh)
|
2013-06-26 |
2017-11-14 |
上海君实生物医药科技股份有限公司 |
抗pd‑1抗体及其应用
|
|
US20160186260A1
(en)
|
2013-07-26 |
2016-06-30 |
Sequenta, Llc |
Cancer vaccination with antigen evolution
|
|
WO2015014375A1
(en)
|
2013-07-30 |
2015-02-05 |
Biontech Ag |
Tumor antigens for determining cancer therapy
|
|
US10077305B2
(en)
|
2013-09-10 |
2018-09-18 |
Medimmune Limited |
Antibodies against PD-1 and uses thereof
|
|
CN112552401B
(zh)
|
2013-09-13 |
2023-08-25 |
广州百济神州生物制药有限公司 |
抗pd1抗体及其作为治疗剂与诊断剂的用途
|
|
US9974849B2
(en)
*
|
2013-10-13 |
2018-05-22 |
Bioventures, Llc |
Human Papilloma virus therapeutic vaccine
|
|
CN104558177B
(zh)
|
2013-10-25 |
2020-02-18 |
苏州思坦维生物技术股份有限公司 |
拮抗抑制程序性死亡受体pd-1与其配体结合的单克隆抗体及其编码序列与用途
|
|
EP3060581A4
(en)
|
2013-10-25 |
2017-06-07 |
Dana-Farber Cancer Institute, Inc. |
Anti-pd-l1 monoclonal antibodies and fragments thereof
|
|
US20160310584A1
(en)
|
2013-12-06 |
2016-10-27 |
The Broad Institute Inc. |
Formulations for neoplasia vaccines
|
|
SG10201804945WA
(en)
|
2013-12-12 |
2018-07-30 |
Shanghai hengrui pharmaceutical co ltd |
Pd-1 antibody, antigen-binding fragment thereof, and medical application thereof
|
|
KR20230076867A
(ko)
|
2013-12-20 |
2023-05-31 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
|
EP3090066A4
(en)
|
2014-01-02 |
2017-08-30 |
Memorial Sloan Kettering Cancer Center |
Determinants of cancer response to immunotherapy
|
|
PL3094351T3
(pl)
|
2014-01-15 |
2022-06-27 |
Kadmon Corporation, Llc |
Środki immunomodulujące
|
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗ｐｄ-ｌ１之人類抗體
|
|
BR112016014952A2
(pt)
|
2014-02-10 |
2017-09-19 |
Merck Patent Gmbh |
Inibição direcionada de tgfbeta
|
|
US20150315247A1
(en)
|
2014-05-04 |
2015-11-05 |
David Charles Binder |
High-affinity peptide-based anticancer vaccination to overcome tumor resistance to immunostimulatory antibodies and to identify TCRs that can be used successfully in adoptive T cell therapy
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
JP6666905B2
(ja)
|
2014-05-29 |
2020-03-18 |
スプリング バイオサイエンス コーポレーション |
Ｐｄ−ｌ１抗体及びその使用
|
|
WO2015195163A1
(en)
|
2014-06-20 |
2015-12-23 |
R-Pharm Overseas, Inc. |
Pd-l1 antagonist fully human antibody
|
|
TWI693232B
(zh)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
|
|
CN106604742B
(zh)
|
2014-07-03 |
2019-01-11 |
百济神州有限公司 |
抗pd-l1抗体及其作为治疗剂及诊断剂的用途
|
|
CN105330740B
(zh)
|
2014-07-30 |
2018-08-17 |
珠海市丽珠单抗生物技术有限公司 |
抗pd-1抗体及其应用
|
|
KR102357893B1
(ko)
|
2014-08-05 |
2022-02-04 |
맵퀘스트 에스아 |
Pd-1 에 결합하는 면역학적 시약
|
|
DK3186283T3
(da)
|
2014-08-29 |
2020-03-02 |
Hoffmann La Roche |
Kombinationsbehandling med tumormålrettede IL-2- immuncytokinervarianter og antistoffer mod humant PD-L1
|
|
EP3191121B1
(en)
|
2014-09-10 |
2020-05-27 |
The University of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
WO2016040900A1
(en)
|
2014-09-14 |
2016-03-17 |
Washington University |
Personalized cancer vaccines and methods therefor
|
|
EA201792501A1
(ru)
*
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
WO2017088080A1
(es)
|
2015-11-25 |
2017-06-01 |
Natural Response S.A. |
Método para la obtención de saponinas a partir de plantas
|
|
MA52363A
(fr)
*
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|